Logo (Actavis) 811 (Indomethacin Extended-Release 75 mg)
Pill with imprint Logo (Actavis) 811 is Beige, Capsule-shape and has been identified as Indomethacin Extended-Release 75 mg. It is supplied by Actavis Inc..
Indomethacin is used in the treatment of gout, acute; back pain; ankylosing spondylitis; bartter syndrome; bursitis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 811
Indomethacin Extended-Release
- Imprint:
- Logo (Actavis) 811
- Strength:
- 75 mg
- Color:
- Beige
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category:
- C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation - CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Inc.
- National Drug Code (NDC):
- 45963-0811
More about indomethacin
- Indomethacin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 156 Reviews
- Drug class: Nonsteroidal anti-inflammatory drugs
- FDA Alerts (5)
Consumer resources
- Indomethacin
- Indomethacin Capsules
- Indomethacin Sustained-Release Capsules
- Indomethacin Injection
- Indomethacin Suppositories
- ... +4 more
Other brands: Indocin, Tivorbex, Indocin SR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
